Wellington Management Group’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-167,831
| Closed | -$305K | – | 1908 |
|
|
2024
Q3 | $305K | Buy |
167,831
+22,114
| +15% | +$40.2K | ﹤0.01% | 1846 |
|
|
2024
Q2 | $879K | Buy |
145,717
+18,680
| +15% | +$113K | ﹤0.01% | 1692 |
|
|
2024
Q1 | $1.42M | Buy |
127,037
+46,349
| +57% | +$517K | ﹤0.01% | 1600 |
|
|
2023
Q4 | $1.2M | Buy |
+80,688
| New | +$1.2M | ﹤0.01% | 1593 |
|
|
2022
Q4 | – | Sell |
-47,586
| Closed | -$455K | – | 1983 |
|
|
2022
Q3 | $455K | Sell |
47,586
-1,080,515
| -96% | -$10.3M | ﹤0.01% | 1820 |
|
|
2022
Q2 | $9.13M | Sell |
1,128,101
-1,681,725
| -60% | -$13.6M | ﹤0.01% | 1148 |
|
|
2022
Q1 | $47.5M | Sell |
2,809,826
-918,504
| -25% | -$15.5M | 0.01% | 770 |
|
|
2021
Q4 | $80.1M | Sell |
3,728,330
-138,812
| -4% | -$2.98M | 0.01% | 691 |
|
|
2021
Q3 | $286M | Buy |
3,867,142
+970,252
| +33% | +$71.7M | 0.05% | 356 |
|
|
2021
Q2 | $158M | Buy |
2,896,890
+235,328
| +9% | +$12.9M | 0.03% | 505 |
|
|
2021
Q1 | $196M | Buy |
2,661,562
+678,456
| +34% | +$50M | 0.03% | 429 |
|
|
2020
Q4 | $171M | Buy |
1,983,106
+948,578
| +92% | +$81.8M | 0.03% | 448 |
|
|
2020
Q3 | $39M | Buy |
+1,034,528
| New | +$39M | 0.01% | 762 |
|